News from other sources...
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content
Information technology
Artificial placenta system aims to help lung development in premature births | The Wall Street Journal
To improve care for extremely premature newborns, researchers have been experimenting with technology that could act as an artificial placenta and mimic the womb environment to give delicate lungs more time to develop.
Q&A: Biotech veteran takes a bolder tech transfer approach at UCSF | STAT
Scores of promising technologies that have been spun out of a university wind up gathering dust, once they've been licensed by a pharmaceutical company. That's because tech transfer offices often license out technology when it's still very early stage — and drug makers at times give up trying to validate them.
Three key investment challenges at the intersection of health and technology | Forbes
By now, we have it on good authority that healthcare is complicated. Apparently, many health curious tech investors have come to similar conclusions.
Pharmaceuticals
AstraZeneca third-line lung cancer trial delayed by few months | Reuters
A clinical study testing AstraZeneca's experimental immunotherapy drugs in lung cancer patients who have already received at least two previous treatments will take longer than initially expected to produce results.
Safety, quality and clinical practice
Is Singapore's "miracle" health care system the answer for America? | Vox
Singapore's health care system is a marvel, but the reasons it works in Singapore are the reasons it wouldn't work in America.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
1 | |
2 | |
3 | |
4 | |
5 |